As of 31 Dec 2025, 38 institutional investors reported holding $729,438,330 in principal (par value) of CONMED CORP - NOTE 2.250% 6/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $729,438,330 | $699,763,518 | +$108,521,731 | 95.82% | 38 |
| 2025 Q3 | $615,311,180 | $587,497,827 | -$15,960,685 | 95.29% | 43 |
| 2025 Q2 | $710,833,520 | $674,963,092 | +$11,276,101 | 94.87% | 52 |
| 2025 Q1 | $696,348,849 | $656,269,027 | -$62,042,835 | 94.15% | 56 |
| 2024 Q4 | $753,934,750 | $703,474,150 | -$31,730,798 | 92.87% | 62 |
| 2024 Q3 | $777,353,000 | $723,159,186 | +$1,047,945 | 92.95% | 56 |
| 2024 Q2 | $780,594,000 | $699,174,345 | -$12,929,783 | 89.54% | 60 |
| 2024 Q1 | $793,857,500 | $731,027,698 | +$11,402,341 | 91.6% | 66 |
| 2023 Q4 | $780,577,200 | $783,996,731 | -$6,917,275 | 100.07% | 70 |
| 2023 Q3 | $765,929,000 | $735,292,140 | +$5,709,385 | 95.4% | 68 |
| 2023 Q2 | $741,865,112 | $831,837,448 | +$831,837,142 | 111.88% | 55 |